Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism

20235 citationsJournal Articlegold Open Access

Authors

Fauzia Ullah · The University of Texas MD Anderson Cancer Center

Juhee Song · The University of Texas MD Anderson Cancer Center

Cristhiam M. Rojas‐Hernandez · The University of Texas MD Anderson Cancer Center

Michael H. Kroll · The University of Texas MD Anderson Cancer Center

C. P. Escalante · The University of Texas MD Anderson Cancer Center

Katy M. Toale · The University of Texas MD Anderson Cancer Center

Abstract

Apixaban and rivaroxaban had a similar risk of recurrent VTE and bleeding and could be considered as anticoagulant options in selected patients with GICA and VTE.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Atrial Fibrillation Management and Outcomes Central Venous Catheters and Hemodialysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Oncologist

Volume 28, Issue 11, pp. e1005-e1016

DOI: 10.1093/oncolo/oyad148

Field-Weighted Citation Impact: 1.42